Combining Prostate-Specific Antigen Parameters With Prostate Imaging Reporting and Data System Score Version 2.0 to Improve Its Diagnostic Accuracy

BACKGROUND: Any non-invasive test that can predict the absence of prostate cancer (PCa) or absence of clinically significant PCa (CSPCa) is necessary, as it can reduce the number of unnecessary biopsies in patients with gray zone prostate-specific antigen (PSA, 4 - 10 ng/mL). This study evaluated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruah, Sasanka Kumar, Das, Nabajeet, Baruah, Saumar Jyoti, Rajeev, T.P., Bagchi, Puskal Kumar, Sharma, Debanga, Phukan, Mandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940033/
https://www.ncbi.nlm.nih.gov/pubmed/31921377
http://dx.doi.org/10.14740/wjon1230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940033/
https://www.ncbi.nlm.nih.gov/pubmed/31921377
http://dx.doi.org/10.14740/wjon1230

Ejemplares similares